DAX23.739 +0,9%ESt505.500 +1,0%Top 10 Crypto15,32 +0,4%Dow46.247 +0,7%Nas22.484 +0,4%Bitcoin93.403 -0,3%Euro1,1704 ±0,0%Öl69,75 +0,2%Gold3.763 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Lufthansa 823212 NVIDIA 918422 DroneShield A2DMAA Novo Nordisk A3EU6F Tesla A1CX3T RENK RENK73 HENSOLDT HAG000 Allianz 840400 Amazon 906866 Deutsche Telekom 555750 BASF BASF11 SAP 716460 Volkswagen (VW) vz. 766403 Siemens Energy ENER6Y
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Inflationsdaten: DAX geht höher ins Wochenende -- US-Börsen fest -- Höhere Trump-Zölle auf Arzneimittel & Co. -- Gerresheimer, Intel, Plug Power, Siemens, Rheinmetall, D-Wave, Oracle im Fokus
Top News
Top-News der Woche: Diese Themen waren diese Woche wichtig Top-News der Woche: Diese Themen waren diese Woche wichtig
So finden Anleger das passende Risikoprofil für ihre Geldanlage So finden Anleger das passende Risikoprofil für ihre Geldanlage
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

MediPharm Labs Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
0,0442 EUR ±0,0000 EUR ±0,00 %
BMN
0,0700 CAD ±0,0000 CAD ±0,00 %
TSX
MediPharm Labs jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.18,06 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N7AA

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINCA58504D1006

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolMEDIF

MediPharm Labs Aktien News

DatumMeistgelesen
PR NewswireCOMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures...
PR NewswireCOMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circular Detailing Prolonged Underperformance, Strategic Failures...
PR NewswireApollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial Results
Wer­bungMediPharm Labs-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireApollo Capital Warns MediPharm Shareholders of Continued Value Destruction and Insolvency Risk Following Disastrous Q1 Financial Results
PR NewswireApollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders
PR NewswireApollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders
PR NewswireApollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
PR NewswireApollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction
PR NewswireMediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
PR NewswireMediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
PR NewswireMediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M
PR NewswireMediPharm Labs Reports Third Quarter Results
PR NewswireMediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
PR NewswireMediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
PR NewswireMediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
PR NewswireMediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
PR Newswire/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
PR NewswireMediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
PR NewswireMediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
PR NewswireMediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
PR NewswireMediPharm Labs Reports First Quarter Results
PR NewswireMediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
PR NewswireMediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
PR NewswireMediPharm Labs Provides Conference Call Recording Details
PR NewswireMediPharm Labs Reports Fourth Quarter and Full Year Results
PR NewswireMediPharm Labs Provides Update on German Cannabis Legalization
PR NewswireMediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results
PR NewswireMediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
PR NewswireMediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
PR NewswireMediPharm Labs Reports Third Quarter Results
PR NewswireMediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results
PR NewswireMediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash
PR NewswireMediPharm Labs Settles an Outstanding Claim for $9M
PR NewswireMediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market
PR NewswireMediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement
PR NewswireMediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million
PR NewswireMediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients
PR NewswireMediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth
PR NewswireMediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results
PR NewswireMediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status

MediPharm Labs News

MediPharm Labs News: auf dieser Seite finden Sie alle MediPharm Labs News und Nachrichten zur MediPharm Labs Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch MediPharm Labs News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um MediPharm Labs News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.